Yamamoto, Yutaro
Katayama, Takuto
Fabbri, Camila
Niwa, Sora
Okuhara, Daiki
Iyori, Mitsuhiro
Hasyim, Ammar A.
Mizukami, Hiroaki
Shida, Hisatoshi
Lopes, Stefanie
Yoshida, Shigeto
Funding for this research was provided by:
Grant-in-Aid for Young Scientists (21K16317)
Fostering Joint International Research grant (21KK0295)
Grant-in-Aid for JSPS Fellows (24KJ0091)
Grant-in-Aid for Scientific Research (19H03458)
SPS Bilateral Joint Research Projects (JPJSBP120205704)
Global Health Innovative Technology Fund (GHIT T2021-256)
Article History
Received: 25 February 2025
Accepted: 12 July 2025
First Online: 26 July 2025
Competing interests
: Authors S.Y., H.S., H.M., and M.I. are credited as inventors of patents concerning viral-vectored malaria vaccines 2022-24221. HS is also credited as an inventor on a pending patent related to LC16m8Δ WO 2005/054451 A1. However, neither of these products has been brought to market. The remaining authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.